J&J Professional Division Is Device Industry's Unsung Hero In 1999
This article was originally published in The Gray Sheet
Johnson & Johnson's commitment to expanding its medical device business, combined with success in executing and managing drug and device acquisitions, made the company one of the few bright lights among large-cap medical device industry issues in 1999.
You may also be interested in...
The ability of the Cooper Companies to build market share in the high-margin toric contact lens sector of the specialty lens market while successfully transforming itself from a health conglomerate into a more focused ophthalmic concern helped focus investors attention and lift the firm's stock price significantly in 1999.
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.